Int J Lab Hematol 2021 Jan 16. Epub 2021 Jan 16.
Czech Myeloma Group, Brno, Czech Republic.
BMC Cancer 2021 Jan 15;21(1):73. Epub 2021 Jan 15.
Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic.
Lancet Oncol 2021 01 7;22(1):142-154. Epub 2020 Dec 7.
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Br J Haematol 2020 Nov 20. Epub 2020 Nov 20.
Department of Haemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic.
Lancet 2020 11;396(10262):1563-1573
General Hospital Evangelismos, Athens, Greece.
Target Oncol 2020 Dec;15(6):807
Amgen Inc., Thousand Oaks, CA, USA.
Ann Hematol 2021 Jan;100(1):297-302
Hematology and Medical Oncology, Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Blood Cancer J 2020 10 16;10(10):102. Epub 2020 Oct 16.
Clinica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain.
Haematologica 2020 10 5;Online ahead of print. Epub 2020 Oct 5.
Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands .
Target Oncol 2020 Oct;15(5):599-611
J Clin Oncol 2020 Dec 6;38(34):4030-4041. Epub 2020 Oct 6.
Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA.
Blood Rev 2020 Sep 15:100758. Epub 2020 Sep 15.
Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790/5, Ostrava 708 52, Czech Republic; Faculty of Medicine, University of Ostrava, Ostrava 703 00, Czech Republic. Electronic address:
Vnitr Lek 2020 ;66(5):90-95
Expert Opin Investig Drugs 2020 Oct 29;29(10):1069-1078. Epub 2020 Sep 29.
Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School , Boston, MA, USA.
Leukemia 2021 01 19;35(1):31-44. Epub 2020 Aug 19.
Erasmus MC Cancer Institute, Erasmus University of Rotterdam, Rotterdam, The Netherlands.
N Engl J Med 2020 08;383(7):617-629
From the Department of Leukemia, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston (C.D.D., M.K.); the Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento (B.A.J.), the Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte (V. Pullarkat), and Genentech, South San Francisco (W.-J.H.) - all in California; the Section of Hematology and Oncology, Department of Medicine, University of Chicago Medicine, Chicago (M.J.T.), and AbbVie, North Chicago (Y.Z., J.P.) - both in Illinois; the Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston (J.S.G., A.L.); the Australian Centre for Blood Diseases, Alfred Hospital and Monash University, Melbourne, VIC (A.H.W.); the Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany (H.D.); Hôpital St. Louis, Assistance Publique-Hôpitaux de Paris and Université de Paris, Paris (P.F.); the Third Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna (E.K.); the Department of Hematology, Cliniques Universitaires Saint-Luc, Brussels (V.H.); the Department of Medicine, McMaster University, Hamilton, ON, Canada (B.L.); the Department of Hematology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute, Barcelona (J.E.); the Institute of Hematology and Hospital of Blood Disease, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin, China (J.W.); the Department of Hematology, University Hospital Dubrava, University of Zagreb School of Medicine, Zagreb, Croatia (V. Pejsa); the Department of Clinic Subjects, University Hospital Ostrava-Poruba, Ostrava, Czech Republic (R.H.); Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki (K.P.); the Faculty of Medicine, Department of Hematology, University of Debrecen, Debrecen, Hungary (A.I.); Hadassah Medical Center, Jerusalem (D.L.); the Clinic of Hematology, Department of Internal Medicine, University of Genoa, and San Martino Hospital IRCCS - both in Genoa, Italy (R.M.L.); the Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan (K.Y.); the Department of Internal Medicine, Seoul National University College of Medicine (S.-S.Y.), and the Department of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine (J.-H.J.) - both in Seoul, South Korea; the Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan (S.-P.Y.); the Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ondokuz Mayıs University, Samsun, Turkey (M.T.); and Abramson Cancer Center, University of Pennsylvania, Philadelphia (K.W.P.).
J Clin Oncol 2020 Oct 30;38(28):3252-3260. Epub 2020 Jul 30.
Amyloidosis Research and Treatment Center "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo," Pavia, Italy.
Oncol Ther 2019 Dec 3;7(2):141-157. Epub 2019 Nov 3.
Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
BMJ Open 2020 07 14;10(7):e034209. Epub 2020 Jul 14.
Institute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland, UK.
Cancers (Basel) 2020 Jul 4;12(7). Epub 2020 Jul 4.
Department of Clinical Studies, Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic.